Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $134B
1-Year Return 51.86%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Quarter Return
-16.55%
1 Year Return
+51.86%
3 Year Return
+235.75%
5 Year Return
+330.72%
10 Year Return
+1,748.3%
AUM
$143B
AUM Growth
-$39.6B
Cap. Flow
-$3.99B
Cap. Flow %
-2.8%
Top 10 Hldgs %
39.86%
Holding
510
New
11
Increased
135
Reduced
148
Closed
12

Top Sells

1
TSLA icon
Tesla
TSLA
$1.06B
2
PBR icon
Petrobras
PBR
$460M
3
BABA icon
Alibaba
BABA
$450M
4
Z icon
Zillow
Z
$381M
5
NVDA icon
NVIDIA
NVDA
$379M

Sector Composition

1 Consumer Discretionary 28.1%
2 Healthcare 23.85%
3 Technology 19.62%
4 Communication Services 11.36%
5 Financials 5.81%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SUMO
451
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$8K ﹤0.01%
726
DCT
452
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
$8K ﹤0.01%
355
MATV icon
453
Mativ Holdings
MATV
$667M
$7K ﹤0.01%
265
NKTR icon
454
Nektar Therapeutics
NKTR
$725M
$7K ﹤0.01%
92
OXM icon
455
Oxford Industries
OXM
$641M
$7K ﹤0.01%
73
BMRN icon
456
BioMarin Pharmaceuticals
BMRN
$11.1B
$6K ﹤0.01%
82
CERS icon
457
Cerus
CERS
$251M
$6K ﹤0.01%
1,143
FGEN icon
458
FibroGen
FGEN
$47.5M
$6K ﹤0.01%
19
NNDM
459
Nano Dimension
NNDM
$291M
$6K ﹤0.01%
1,600
VUZI icon
460
Vuzix
VUZI
$186M
$6K ﹤0.01%
924
NVTA
461
DELISTED
Invitae Corporation
NVTA
$6K ﹤0.01%
800
AGIO icon
462
Agios Pharmaceuticals
AGIO
$2.15B
$5K ﹤0.01%
186
FOLD icon
463
Amicus Therapeutics
FOLD
$2.51B
$5K ﹤0.01%
538
FVRR icon
464
Fiverr
FVRR
$875M
$5K ﹤0.01%
61
INGN icon
465
Inogen
INGN
$224M
$5K ﹤0.01%
141
MASS icon
466
908 Devices
MASS
$196M
$5K ﹤0.01%
249
PACB icon
467
Pacific Biosciences
PACB
$375M
$5K ﹤0.01%
561
TSVT
468
DELISTED
2seventy bio
TSVT
$5K ﹤0.01%
286
ZD icon
469
Ziff Davis
ZD
$1.56B
$5K ﹤0.01%
53
ONEM
470
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
$5K ﹤0.01%
445
AGX icon
471
Argan
AGX
$2.82B
$4K ﹤0.01%
103
AMRX icon
472
Amneal Pharmaceuticals
AMRX
$3B
$4K ﹤0.01%
853
+401
+89% +$1.88K
AXGN icon
473
Axogen
AXGN
$730M
$4K ﹤0.01%
444
-250,991
-100% -$2.26M
BLUE
474
DELISTED
bluebird bio
BLUE
$4K ﹤0.01%
43
CGNT icon
475
Cognyte Software
CGNT
$636M
$4K ﹤0.01%
369